TBC1D5-Catalyzed Cycling of Rab7 Is Required for Retromer-Mediated Human Papillomavirus Trafficking during Virus Entry.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
09 06 2020
Historique:
received: 30 09 2019
revised: 16 04 2020
accepted: 18 05 2020
entrez: 11 6 2020
pubmed: 11 6 2020
medline: 20 5 2021
Statut: ppublish

Résumé

During virus entry, human papillomaviruses are sorted by the cellular trafficking complex, called retromer, into the retrograde transport pathway to traffic from the endosome to downstream cellular compartments, but regulation of retromer activity during HPV entry is poorly understood. Here we selected artificial proteins that modulate cellular proteins required for HPV infection and discovered that entry requires TBC1D5, a retromer-associated, Rab7-specific GTPase-activating protein. Binding of retromer to the HPV L2 capsid protein recruits TBC1D5 to retromer at the endosome membrane, which then stimulates hydrolysis of Rab7-GTP to drive retromer disassembly from HPV and delivery of HPV to the retrograde pathway. Although the cellular retromer cargos CIMPR and DMT1-II require only GTP-bound Rab7 for trafficking, HPV trafficking requires cycling between GTP- and GDP-bound Rab7. Thus, ongoing cargo-induced membrane recruitment, assembly, and disassembly of retromer complexes drive HPV trafficking.

Identifiants

pubmed: 32521275
pii: S2211-1247(20)30730-0
doi: 10.1016/j.celrep.2020.107750
pmc: PMC7339955
mid: NIHMS1603430
pii:
doi:

Substances chimiques

GTPase-Activating Proteins 0
TBC1D5 protein, human 0
Vesicular Transport Proteins 0
rab7 GTP-Binding Proteins 0
rab7 GTP-binding proteins, human 0
rab GTP-Binding Proteins EC 3.6.5.2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

107750

Subventions

Organisme : NCI NIH HHS
ID : P01 CA016038
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI102876
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA037157
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI055403
Pays : United States

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):E4717-25
pubmed: 26261320
Methods Mol Biol. 2015;1270:437-51
pubmed: 25702134
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1446-E1454
pubmed: 29386389
Nat Commun. 2016 Nov 09;7:13305
pubmed: 27827364
J Cell Sci. 2009 Jul 15;122(Pt 14):2371-82
pubmed: 19531583
Annu Rev Cell Dev Biol. 2019 Oct 6;35:131-168
pubmed: 31399000
Traffic. 2016 Jul;17(7):709-19
pubmed: 27103185
Methods Mol Biol. 2009;531:57-69
pubmed: 19347311
Cell. 2018 Sep 6;174(6):1465-1476.e13
pubmed: 30122350
J Cell Sci. 2010 Nov 1;123(Pt 21):3703-17
pubmed: 20923837
Front Cell Dev Biol. 2019 Aug 14;7:139
pubmed: 31475144
J Neurosci. 2008 Feb 13;28(7):1640-8
pubmed: 18272684
Comput Methods Programs Biomed. 2009 Apr;94(1):58-65
pubmed: 18950895
Nature. 2006 Jul 20;442(7100):303-6
pubmed: 16855591
Cell. 2016 Dec 1;167(6):1623-1635.e14
pubmed: 27889239
Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):E11151-E11160
pubmed: 29229824
J Virol. 2019 Jul 17;93(15):
pubmed: 31092566
PLoS Pathog. 2014 May 29;10(5):e1004162
pubmed: 24874089
mBio. 2014 Sep 16;5(5):e01777-14
pubmed: 25227470
J Cell Sci. 2018 Jun 21;131(12):
pubmed: 29777037
J Virol. 2016 Oct 28;90(22):10120-10132
pubmed: 27581988
PLoS Pathog. 2012;8(4):e1002657
pubmed: 22536154
Cell. 1994 Jun 17;77(6):895-907
pubmed: 8004676
J Cell Biol. 1982 Apr;93(1):97-102
pubmed: 7068762
J Cell Sci. 2012 Oct 15;125(Pt 20):4693-702
pubmed: 23148298
Neurobiol Aging. 2012 Sep;33(9):2231.e15-2231.e30
pubmed: 22673115
Proc Natl Acad Sci U S A. 2016 May 31;113(22):6289-94
pubmed: 27190090
Science. 1993 Mar 5;259(5100):1466-8
pubmed: 8451644
J Cell Sci. 2007 Jul 15;120(Pt 14):2378-89
pubmed: 17606993
EMBO J. 2000 Aug 1;19(15):3905-17
pubmed: 10921873
Nat Protoc. 2016 Mar;11(3):456-75
pubmed: 26866790
Front Cell Dev Biol. 2018 Oct 02;6:129
pubmed: 30333976
Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12513-8
pubmed: 11070078
Cells. 2016 Aug 18;5(3):
pubmed: 27548222
Dev Cell. 2014 Jun 9;29(5):591-606
pubmed: 24856514
J Biol Chem. 2001 Dec 21;276(51):47834-9
pubmed: 11592960
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10978-83
pubmed: 11005870
PLoS Pathog. 2017 May 2;13(5):e1006308
pubmed: 28464022
J Cell Biol. 2008 Nov 3;183(3):513-26
pubmed: 18981234
Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7452-7
pubmed: 23569269
Nat Commun. 2017 Nov 16;8(1):1543
pubmed: 29146912
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):267-72
pubmed: 24344282
Oncogene. 2005 Nov 21;24(52):7756-62
pubmed: 16299535
Int J Mol Sci. 2018 Sep 04;19(9):
pubmed: 30181457
PLoS Pathog. 2015 Feb 18;11(2):e1004699
pubmed: 25693203
Cold Spring Harb Perspect Biol. 2014 Feb 01;6(2):
pubmed: 24492709
J Cell Sci. 2018 Sep 3;131(17):
pubmed: 30111580
J Cell Sci. 2010 Mar 1;123(Pt 5):756-66
pubmed: 20164305
Mol Biol Cell. 2012 Jul;23(13):2505-15
pubmed: 22593205
Traffic. 2012 Mar;13(3):455-67
pubmed: 22151726
Traffic. 2015 Jan;16(1):68-84
pubmed: 25367362
J Biol Chem. 1993 Jun 5;268(16):12083-9
pubmed: 8505331
EMBO J. 2018 Jan 17;37(2):235-254
pubmed: 29158324
J Virol. 2018 Feb 26;92(6):
pubmed: 29321327
Traffic. 2019 Jul;20(7):465-478
pubmed: 30993794
J Virol. 2013 Apr;87(7):3862-70
pubmed: 23345514
Nature. 1993 Aug 19;364(6439):732-4
pubmed: 8355790
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3447-52
pubmed: 20142506
Methods Mol Med. 2005;119:445-62
pubmed: 16350417
J Virol. 1998 May;72(5):3925-34
pubmed: 9557678
J Cell Biol. 2004 Apr;165(1):111-22
pubmed: 15078902
J Cell Biol. 2019 Feb 4;218(2):615-631
pubmed: 30559172

Auteurs

Jian Xie (J)

Department of Genetics, Yale School of Medicine, PO Box 208005, New Haven, CT 06520-8005, USA.

Erin N Heim (EN)

Department of Genetics, Yale School of Medicine, PO Box 208005, New Haven, CT 06520-8005, USA.

Mac Crite (M)

Department of Microbial Pathogenesis, Yale School of Medicine, 295 Congress Avenue, New Haven, CT 06519, USA.

Daniel DiMaio (D)

Department of Genetics, Yale School of Medicine, PO Box 208005, New Haven, CT 06520-8005, USA; Department of Therapeutic Radiology, Yale School of Medicine, PO Box 208040, New Haven, CT 06520-8040, USA; Department of Molecular Biophysics & Biochemistry, Yale School of Medicine, PO Box 208024, New Haven, CT 06520-8024, USA; Yale Cancer Center, PO Box 208028, New Haven, CT 06520-8028, USA. Electronic address: daniel.dimaio@yale.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH